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Abstract 
Background The bronchodilator response (BDR) is frequently used to support diagnostic and 
therapeutic decision-making for children who wheeze. However, there is little evidence-
based guidance describing the role of BDR testing in preschool children and it is unclear 
whether published cut-off values, which are derived from adult data, can be applied to this 
population. 
Methods We searched MEDLINE, EMBASE, Web of Science and Cochrane databases 
(inception - September 2015) for studies reporting response to a bronchodilator in healthy 
preschool children, response following placebo inhalation, and the diagnostic efficacy of 
BDR compared with a clinical diagnosis of asthma/recurrent wheezing.  
Findings We included 14 studies. Thirteen studies provided BDR data from healthy 
preschool children. Two studies reported response to placebo in preschool children with 
asthma/recurrent wheezing. Twelve studies compared BDR measurements from preschool 
children with asthma/recurrent wheeze to those from healthy children and seven of these 
studies reported diagnostic efficacy. Significant differences between the BDR measured in 
healthy preschool children compared with that in children with asthma/recurrent wheeze 
were demonstrated in some, but not all studies. Techniques such as interrupter resistance, 
oscillometry and plethysmography were more consistently successfully completed than 
spirometry. Between study heterogeneity precluded determination of an optimum 
technique. 
Interpretation There is little evidence to suggest spirometry-based BDR can be used in the 
clinical assessment of preschool children who wheeze. Further evaluation of simple 
alternative techniques is required. Future studies should recruit children in whom airways 
disease is suspected and should evaluate the ability of BDR testing to predict treatment 
response.
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Introduction  
In school-aged children and adults asthma is diagnosed clinically using patient history and 
objective investigations which include respiratory function testing1. In adults and older 
children the bronchodilator response (BDR) can be used to quantify reversible airways 
obstruction and to support diagnostic and therapeutic decision-making. ERS guidelines for 
adult patients recommend that an increase in forced expiratory volume in the first second 
of expiration (FEV1) of 200 ml and 12% of the baseline value represents a positive BDR test1. 
More recently, a guideline for asthma diagnosis and management has been proposed; this 
endorsed these cut-offs but found no evidence against which to assess their use in children2. 
No guidance at all was provided relating to objective testing of preschool-aged children, 
(normally 2 – 5 years of age inclusive).  
It is unlikely that adult guidelines can be applied to preschool-aged children. A cut-off based 
upon absolute increase in FEV1 does not account for changes in lung size with growth. 
Similarly, whilst expressing the increase as a percentage of baseline might adjust for lung 
size1,2, it remains unclear whether percentage cut-offs derived from adult data can be 
applied to preschool children. Finally, difficulties associated with technique and cooperation 
are likely to limit the accuracy and repeatability of spirometry-based BDR testing in young 
children3. Alternative techniques have been developed and the American and European 
Respiratory Societies have published a position statement on preschool lung function 
testing4. This was based upon literature published before 2007, it offered little guidance on 
the best method to measure and express BDR in preschool children and did not present 
definitive cut-off values.  
This review sought to systematically assess studies relating to BDR determination in 
preschool children, including those published since the ATS/ERS statement. First, to 
determine a clinically meaningful and significant response to bronchodilator we reviewed 
studies describing the magnitude of BDR in healthy preschool children or change in lung 
function following placebo inhalation in preschool children with wheezing disorders. 
Second, we reviewed studies assessing the ability of the BDR to discriminate healthy 
preschool children from those with asthma or recurrent wheezing. Finally, we considered 
the optimal means of measuring and expressing BDR in preschool children. 
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Methods 
This review was conducted according to a prospectively designed protocol (online 
supplementary material). 
Search strategy 
Potentially eligible studies were identified from MEDLINE, EMBASE, Web of Science and the 
Cochrane Database. Searches were built to identify all English language studies referencing 
bronchodilator response or a variant or abbreviation of this in the title or abstract. Studies 
were limited to those conducted in humans and preschool-aged participants. Searches were 
run from the inception of each database until 25th September 2015. Additional studies were 
identified by manually checking the citations of each study selected for inclusion. 
Study selection 
Studies of preschool children were included if they presented numerical data describing 
either BDR in healthy children alone or comparing this with BDR in children with asthma or 
recurrent wheeze. Eligible studies included those measuring either response to 
bronchodilator in healthy control children, or change in lung function following placebo 
inhalation in children with asthma or recurrent wheeze. Where possible the clinically 
significant or meaningful bronchodilator response cut-off was calculated. The method of 
Sourk and Nugent was used to calculate a cut-off which included only the greatest 5% of 
responses found in healthy preschool children5. To assess diagnostic efficacy, studies 
comparing the response to bronchodilator in preschool children with asthma or recurrent 
wheeze to that in those without were identified. All methods of measuring and expressing 
the bronchodilator response were permitted. Piloting the inclusion criteria revealed that 
many studies were not strictly limited to children conventionally considered of preschool 
age. Studies were included if no participant was aged 7 years or older and at least two thirds 
of the participants were 2 years of age or older but younger than 6 years. Studies displaying 
data from preschool-aged children separately from data from older individuals were also 
eligible for inclusion. To reduce the influence of outliers upon BDR cut-off, studies were also 
excluded if the number of participants per group was low (less than 20). Modified QUADAS-
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2 criteria were used to assess study quality6. (Table S1) Following current recommendations, 
formal scores were not assigned but a subjective assessment made and summarised7. 
Data synthesis 
Considerable heterogeneity was expected with respect to participants’ diagnoses and 
included studies’ choice of physiological parameters, BDR protocol and method of BDR 
expression. For this reason no meta-analyses were planned. However, where possible the 
results of studies of comparable physiological parameters were compared. For simplicity, 
where multiple means of expression were employed, comparisons were made using BDR 
expressed as percentage change in lung function relative to baseline since this mode of 
expression is recommended in ERS guidelines and we wished to assess the applicability of 
this guideline to the preschool population1. 
 
Results 
Study selection and quality 
After excluding duplicates, 254 studies were screened, 22 full papers assessed and fourteen 
selected for inclusion (Figure 1 & Table 1). One study measured BDR in healthy preschool 
children only8, 12 provided BDR data from healthy children alongside measurements from 
children with asthma or recurrent wheeze, 12 compared BDR in preschool children with 
asthma or recurrent wheeze to that in those without, and seven reported diagnostic 
sensitivity and specificity. Two studies measured change in lung function following placebo 
inhalation in children with asthma or recurrent wheeze9,10.(Table 1) Using modified 
QUADAS-2 criteria study quality was moderate(Table S2). However, few studies stated 
whether the BDR test was applied independently of the reference standard,not all studies 
followed the ERS protocol completely, and many selected a threshold to maximise 
sensitivity and specificity in the study population11-14. BDR was not tested in every 
participant in every study, younger and healthy children were less likely to complete 
testing8. Most studies reporting diagnostic efficacy, rather than apply the BDR test to 
individuals under investigation for wheezing disorders, used a case-control design, 
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comparing the BDR measured in preschool children with asthma or recurrent wheeze to 
that in healthy children.  
 
Spirometry BDR in healthy preschool children 
The largest study of BDR in preschool children without asthma presented data from 42 
children. These children although currently healthy were at high risk of asthma due to 
previous wheeze15. Three smaller studies included 30 children or fewer (Table 2)9, 11, 14. In 
one only seven of the 30 participants achieved an expiratory time greater than one 
second11. Shin et al selected children for testing based upon ability to complete the testing 
protocol14. In the remaining studies success ranged from 23% to 95%9,11,15, and within 
studies success rates increased with age9. No study reported an upper 95% confidence limit 
for healthy preschool children. This could be calculated as 19% and 13%, respectively, from 
Borrego et al’s and Shin et al’s data (Table 2).Two studies reported change in FEF0.75 
following bronchodilator (calculated upper 95% confidence limits both 15%)9,14 and two 
reported change in FEV0.5 (calculated upper 95% confidence limits 22% and 20%)11,14.  
 
Spirometry response after placebo inhalation in preschool children with asthma  
Borrego et al reported percentage change relative to baseline following placebo inhalation 
for 43 preschool children with mild-moderate doctor-diagnosed asthma9. The mean (SD) 
reported changes for FEV1 and FEV0.75 were 2.6% (7.5%) and 2.1% (5.2%), equating to upper 
95% confidence limit cut-offs of 18% and 13% respectively(Table 2). 
 
Ability of spirometry BDR to identify children with asthma or recurrent wheeze 
Four studies reported spirometry BDR data from both healthy preschool children and those 
with asthma or recurrent wheeze9,11,14,15, although one included only 7 healthy children with 
successful FEV1 measurements11(Table S4). BDR protocol, diagnostic criteria, asthma 
severity and treatment level varied between studies. No study measured diagnostic 
sensitivity and specificity for spirometry-based BDR in preschool children with respiratory 
symptoms potentially attributable to asthma. However Marotta et al measured BDR in 
children at high risk of asthma due to previous wheeze. No significant difference between 
those with and without asthma was found in this study15. By contrast, three case-control 
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studies comparing healthy preschool children to those with doctor-diagnosed asthma found 
significant between-group differences in BDR9,11,14.(Table S4) Using cut-offs optimised to the 
population tested Shin et al reported 80% sensitivity and 72% specificity associated with a 
5.3% FEV1 increaserelative to baseline14, whilst Linares Paserini et al reported 30% 
sensitivity and 90% specificity using an 11% FEV0.5 increase relative to baseline11. Borrego et 
al reported that 15% of healthy preschool children had a greater than 12% increase relative 
to baseline9, no study presented both sensitivity and specificity of a 12% cut-off. 
 
Alternatives to spirometry  
Interrupter resistance 
Three case-control interrupter resistance (Rint) studies compared data from healthy 
preschool children with those with asthma or recurrent wheeze12,13,16(Table S5). The only 
reported test failures were four of the 41 healthy children studied by Nielsen et al who did 
not tolerate wearing a facemask. These studies contained between 37 and 82 children in 
each group. Two studies reported mean percentage changes in Rint relative to baseline of -
8%16to -9.7%13, respectively; corresponding5th percentiles in healthy children were -32% and 
-25%. Mele et al used the 5th percentile from healthy children to identify children who not 
only had a history of recurrent wheeze but were also currently symptomatic; 35% sensitivity 
and 93% specificity were found16. Two studies proposed cut-offs based upon optimising 
sensitivity and specificity within their population. In one, a 20% cut-off relative to baseline 
was associated with 76% sensitivity and 80% specificity12 whilst the other found 58% 
sensitivity and 70% specificity using a cut-off of 2.5 intra-subject standard deviations of 
baseline Rint13.  
 
Forced oscillometry   
A study recruiting 154 healthy preschool children8 reported a 5th percentile value for change 
in respiratory system resistance at 8 Hz (Rrs8) relative to baseline of -34% and a 95th 
percentile for change in respiratory system reactance at 8 Hz (Xrs8) of 61%.(Table S5) There 
were three case-control FOT studies. One reported an unexpected greater decrease in Rrs8 
relative to baseline following bronchodilator in healthy children than in those with asthma; 
(median (10th, 90th percentiles) -18.7% (-35.0, -4.4%) versus -16.0% (-33.1, 9.7%))17. 
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Unsurprisingly, using the 5th percentile for healthy children (-37% of baseline) as a cut-off 
yielded low sensitivity (2%). Relative changes in respiratory admittance data from this 
cohort also failed to demonstrate significant differences between healthy children and 
those with asthma18. Oostveen et al found absolute change in Rrs4 and percentage change 
in area under the reactance curve relative to baseline to be most discriminative for 
identifying persistent wheezing19; fifth percentile values for -5.5 hPasL-1 and -31 hPasL-1 
were associated with 13% and 23% sensitivity respectively with 96% specificity in both 
cases. Overall success rates were 85%-95% increasing with age up to 100% in children aged 
4 years or older.  
 
Impulse Oscillometry 
An early Impulse Oscillometry (IOS) study by Hellinckx et al measured BDR in 228 healthy 
children and in those with mild asthma; BDR did not differ significantly between the two 
groups20 so results were combined, the 95th percentile for Rrs5 was -41.4%. Four further 
studies reported measures of respiratory resistance in healthy children alongside 
measurements made in children largely recruited from outpatient clinics with potentially 
more severe asthma or wheeze13-15,21. Successful tests were completed in 80-90% of 
participants. Where reported, the mean change relative to baseline in Rrs5 for healthy 
children ranged from -9.5% to -17%. The only study to report the 5th percentile in healthy 
children reported a value of -29%13. Only one study compared BDR measured in children 
with and without asthma within a high risk population15. Median (IQR) percentage change 
Rrs5 relative to baseline values for 28 children with asthma were -17.0 % (-32.8% to -9.9%) 
and -26.9% (-39.2% to -17.1%) for 45 children without asthma but at high risk due to 
previous wheeze. The difference in median BDR between those with and without asthma 
was greater still for atopic children. Two studies used receiver operator characteristic (ROC) 
curves to optimise diagnostic efficacy. Nielsen et al reported 76% sensitivity and 65% 
specificity using a cut-off of one within subject SD in pre-bronchodilator Rrs513. Shin et al 
reported 87% sensitivity and 62% in using an Rrs5 cut-off of -15.6% relative to baseline14.  
 
Plethysmography  
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One study measured change in specific airways resistance (sRaw) relative to baseline using 
plethysmography13. Mean BDR was -16.3% in 37 healthy preschool children and the 95th 
percentile was -32%, optimal sensitivity (66%) and specificity (81%) were associated with a 
cut-off of three within individual standard deviations (difference between two baseline 
measurements / √2). Measurement failed due to facemask intolerance in 10% of children. 
Comparison of spirometry and alternative measures of lung function  
Few studies compared multiple techniques and comparisons between studies were limited 
by methodological differences. Success rates varied most between studies for spirometry 
but overall spirometry generally had lower success than other techniques. Three studies 
compared the discriminative ability of impulse oscillometry with that of spirometry. Two 
studies found the IOS technique but not spirometry BDR significantly different between 
healthy preschool children and those with asthma or wheeze15,21, whilst another study 
considered spirometry superior based upon area under a ROC curve14. Also using ROC 
analysis Nielsen and Bisgaard found plethysmographic sRaw more discriminative than Rint 
or FOT measures13.  
Comparison of methods of expressing the BDR 
Mele et al reported that absolute changes in Rint in their study were not associated with 
baseline values and that absolute or z-score change in Rint were associated with greater 
sensitivity and specificity than either change in percentage of baseline or predicted values16. 
Similarly, Oostveen et al found BDR based upon absolute FOT values more frequently 
distinguished children with persistent wheeze from those without than did BDR based upon 
relative change19. In contrast, Calogero et al found absolute BDR values to be associated 
with height and recommended expression in terms of change as a percentage of predicted 
value or as change in z-score to avoid this issue8. Simpson et al found a significant difference 
in percentage change in Rrs8 relative to baseline between children with asthma and those 
without, but no difference using absolute BDR values18.  
 
Discussion 
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This review found evidence that spirometry-based BDR can be performed in preschool 
children but success rates vary and are generally low likely reflecting the experience of the 
laboratory. Furthermore, the ability to distinguish healthy children from those with asthma 
or recurrent wheeze is limited by both variability associated with repeated measures and by 
the overlap between BDR measurements made in these groups. There is also evidence that 
BDR can be measured in preschool-aged children using a number of alternative techniques, 
including interrupter resistance, oscillometry, and plethysmography. Whilst many of these 
alternative techniques require specialist expertise to conduct, interpret or both, BDR 
measured using these techniques has been demonstrated to differ significantly between 
healthy children and those with asthma or recurrent wheeze. Unfortunately, few studies 
have directly compared these techniques and there is insufficient evidence that any 
technique is superior.  
Recently, attention has focused upon the contribution of objective testing to asthma 
diagnosis. The NICE guideline for ‘diagnosing and monitoring asthma in adults, children and 
young people’ recommends spirometry BDR testing should be offered to adults and children 
greater than 5 years of age with a FEV1/FVC ratio < 70%2. However, no preschool study 
supported the use of a 200 ml absolute increase in FEV1 in association with a 12% increase 
relative to baseline in this population. An absolute cut-off based upon adult data is unlikely 
to be valid in children due to differences in lung size. Moreover, the between occasion 
variability demonstrated in placebo studies suggests that poor technique may limit the 
repeatability of spirometry measurements in preschool-aged children, potentially increasing 
the relative change necessary to exceed spontaneous variability9,10.  
Ultimately the low success rates associated with spirometry in preschool children unless 
assessed in a specialist laboratory limit its usefulness in this population. Unfortunately, 
whilst numerous alternative techniques have been used in both healthy children and those 
with wheezing disorders11-19,21, there is insufficient evidence to identify the optimal means 
of measuring BDR in children who wheeze. We note, however, that some techniques have 
been demonstrated to be superior to spirometry for quantifying other lung diseases in this 
age group, for example multiple breath wash out in cystic fibrosis22. Similarly the optimal 
means of expressing BDR requires further investigation. Since changes in lung function occur 
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with both growth and disease, a measure of BDR should be independent of both height and 
baseline lung function. Whilst this has led to proposals that BDR should be expressed either 
as a z-score change8, 23or as a percentage of predicted13, both approaches need testing in 
well powered studies. 
In this review we used broad search terms within a comprehensive literature search to 
systematically review data relating to BDR determination in preschool children. We were 
able to identify studies describing a clinically significant BDR and diagnostic efficacy in 
preschool children using spirometry and alternative techniques. Our conclusions are 
constrained by the quality and variability of identified studies. Many studies recruited very 
small numbers of children and few, if any, recruited adequate numbers to be considered 
reliable reference data24. Potential sources of bias include the low number of studies 
assessing diagnostic efficacy in a clinically relevant population of individuals, and the high 
number of studies using a case-control design or selecting a threshold to maximise 
sensitivity and specificity. A further problem was incomplete and inconsistent reporting of 
results and methodology. Heterogeneity precluded meta-analysis and limited the 
comparisons that could be made between studies.  
Given the predominance of case-control designs, it is difficult to assess the diagnostic 
efficacy of BDR within a clinical population of children with symptoms potentially 
attributable to asthma. A cut-off which theoretically best discriminates health from disease 
can be calculated from receiver operator characteristic curves. However, where significant 
overlap exists between healthy individuals and those potentially requiring treatment clinical 
factors should be considered before deciding a threshold. The relative weight placed upon 
sensitivity and specificity may differ according to age. For example, lower cut-offs increase 
sensitivity but may increase the risk of over-treatment with inhaled steroids leading to 
undesirable effects upon young children’s growth25. An important criterion by which to 
judge a diagnostic test is the test’s ability to predict response to treatment; this is 
particularly the case for conditions such as asthma where there is no gold-standard test 
beyond clinical diagnosis. Pertinent to this issue are observations in both children and adults 
that greater bronchodilator responses were measured in individuals responding to inhaled 
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steroids26,27; and some evidence that BDR can predict treatment response in preschool 
children with wheeze28.  
Current guidelines recommend measuring spirometry BDR as a component in the diagnostic 
pathway for asthma but are not based on evidence relevant to children and no 
recommendations are made for preschool-aged children. Clear evidence-based guidelines 
are needed to ensure the correct patients receive trials of asthma treatments. Our findings 
have implications for practice in terms of serving as a reminder that healthy children 
demonstrate considerable BDR which overlaps with that seen in children with asthma or 
other wheezing disorders. Based upon available evidence spirometry does not appear fit for 
this purpose in preschool-aged children, although other techniques may be better and merit 
further evaluation. The relative lack of high quality published data to inform clinical decision 
making suggests further studies are required. Recommendations for further research 
include studies of 1) BDR in children suspected of having a chronic wheezing disorder, 2) the 
ability of BDR to predict treatment response, and 3) new techniques which can be reliably 
conducted outside of a specialist lung function laboratory.  
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Figure 1. PRISMA flow diagram 
